Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events

Hypertension Research

Volumn 25, Issue 5, 2002, Pages 669-676

  Suzuki, Makoto ^a   Hamada, Mareomi ^a   Yamamoto, Kozo ^a   Kazatani, Yukio ^a   Hiwada, Kunio ^a  

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Aging; Cardiac hypertrophy; Cardiovascular events; Hypertension; Natriuretic peptides

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; RENIN;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; PULSE PRESSURE; RISK ASSESSMENT; RISK FACTOR; BLOOD; BLOOD PRESSURE; DISEASE FREE SURVIVAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING;

AGED; AGING; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD PRESSURE; CATECHOLAMINES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RENIN; RISK FACTORS;

EID: 0036749111     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.669     Document Type: Article

References (27)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
2. Insua JT, Sacks HS, Lau T-S, et al: Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med 1994; 121: 355-362.
3. Bennet NE: Hypertension in the elderly. Lancet 1994; 344: 447-449.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
5. Omland T, Aakvaag A, Bonarjee VVS, et al: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963-1969.
6. de Lemos JA, Morrow DA, Bentley JH, et al: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
7. Suzuki M, Yamamoto K, Watanabe S, Iwata T, Hamada M, Hiwada K: Association between elevated brain natriuretic peptide levels and the development of hypertrophy in patients with hypertension. Am J Med 2000; 108: 627-633.
8. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
9. Sahn DJ, DeMaria A, Kisslo J, Weyman A; the Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
10. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618.
11. Suzuki M, Hamada M, Hiwada K: Ejection flow dynamics assessed by ventricular impulse and elastance in the human hypertensive heart. Hypertens Res 1994; 17: 123-131.
12. de Simone G, Devereux RB, Roman MJ, et al: Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444-1451.
13. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K: Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995; 13: 155-160.
14. Kawakami K, Okayama H, Hamada M, Hiwada K: Alteration of atrial natriuretic peptide and brain natriuretic peptide gene expression associated with progression and regression of cardiac hypertrophy in renovascular hypertensive rats. Clin Sci 1996; 90: 197-204.
15. Nishikimi T, Yoshihara F, Morimoto A, et al: Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
16. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM: Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990; 67: 871-885.
17. Olivetti G, Melissari M, Capasso JM, Anversa P: Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560-1568.
18. Sasaki O, Hamada M, Hiwada K: Effect of coronary blood flow on left ventricular functions in patients with essential hypertension. Hypertens Res 2000; 23: 239-245.
19. Nakagawa O, Ogawa Y, Itoh H, et al: Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 1995; 96: 1280-1287.
20. Marumoto K, Hamada M, Hiwada K: Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 1995; 88: 551-556.
21. Capasso JM, Malhotra A, Scheuer J, Sonnenblick EH: Myocardial biochemical, contractile, and electrical performance after imposition of hypertension in young and old rats. Circ Res 1986; 58: 445-460.
22. Rakusan K, Flanagan MF, Geva T, Southern J, Praagh RV: Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86: 38-46.
23. Madhavan S, Ooi WL, Cohen H, Alderman MH: Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401.
24. Verdecchia P, Schillaci G, Reboldi G, Franklin SS, Porcellati C: Different prognostic impact of 24-hour mean blood pressure and pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001; 103: 2579-2584.
25. Yamamoto K, Burnett JC Jr, Jougasaki M, et al: Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994.
26. Tsutamoto T, Wada A, Maeda K, et al: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516.
27. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W: Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 2001; 38: 1934-1941.